LATEST ARTICLES
Canada
Smart & Biggar
On March 26, 2024, the Federal Court dismissed Medexus and Medac's action for patent infringement of Canadian Patent No 2,659,662 (the 662 Patent)...
Smart & Biggar
On November 10, 2021, the Minister of Health refused to reassess its decision that Janssen's esketamine hydrochloride product (SPRAVATO)...
DiliTrust Canada Inc.
In the complex world of pharmaceutical contracts, mistakes are costly. Every deal made and every rule imposed come with risks that can negatively impact not only financial outcomes...
DiliTrust Canada Inc.
Efficient contract management in the pharma industry is crucial, considering the sector's unique blend of innovation and stringent regulation. As a cornerstone of industry operations...
Torys LLP
In Palmer v. Teva Canada Limited1, the Ontario Court of Appeal dismissed the plaintiffs' appeal from the lower court's decision denying certification of a proposed product liability class action that claimed damages...
Goodwin Procter LLP
On March 18, 2024, Fresenius Kabi ("Fresenius") and Formycon announced a settlement agreement with Johnson & Johnson regarding FYB202, a proposed ustekinumab biosimilar to STELARA in Europe and Canada.
Smart & Biggar
On February 16, 2024, the Minister of Health tabled the 2022 Annual Report of the Patented Medicine Prices Review Board (PMPRB).
Smart & Biggar
On February 29, 2024, the Minister of Health announced the introduction of Bill C-64, An Act respecting pharmacare (Pharmacare Act), which "proposes the foundational principles...
Smart & Biggar
On February 23, 2024, Health Canada announced that it will expand the information available on the Generic Submissions Under Review (GSUR) list to include the following...
Smart & Biggar
In this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March 2023 update.
Smart & Biggar
On March 7, 2024, Health Canada published a Memorandum of Understanding (MOU) with the Competition Bureau (together, Participants) to advance their mutual interests and develop a framework...
Oyen Wiggs Green & Mutala LLP
An application for leave to appeal the decision in Apotex Inc. v. Janssen Inc., 2024 FCA 9 has been filed by Apotex in the Supreme Court of Canada (SCC).
Blake, Cassels & Graydon LLP
Welcome to the March edition of Blakes upRound, a regular publication from the Blakes Emerging Companies & Venture Capital (EC&VC) group...
Fasken
On January 26, Health Canada issued a notice clarifying how a drug's "dormant" status on the drug product database may affect whether that drug...
Fasken
The federal Parliament tabled Bill C-64, An Act respecting pharmacare (the "Bill"), on February 29, 2024. The Bill outlines the first phase of the federal government's...
Fasken (French)
Le 26 janvier, Santé Canada a publié un avis précisant comment l'état « dormant » d'un médicament dans la base de données sur les produits pharmaceutiques...
Cassels
The Patented Medicine Prices Review Board Canada (PMPRB) published its "What We Learned Report" (Report) on February 15, 2024...
Aird & Berlis LLP
For many Canadians, pharmaceutical names are an alphabet soup. Biogen's BYOOVIZ and Novartis's BEOVU trademarks are classic examples of drug brand names comprised of coined words.
Gowling WLG
Once you decide to file a patent, you must determine what it will cover. Obviously, you need to protect your invention, but to reduce the risk of others designing around your patent in the future...
Bennett Jones LLP
The Canadian Venture Capital Association (CVCA) released its annual look at the state of venture capital (VC) funding in Canada in their 2023 Market Overview.
Mondaq Webinars
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Comparative Guides
Curated Content
Alberta Court Upholds Express Employee Agreement On Random Drug And Alcohol Testing
Stikeman Elliott LLP
Stikeman Elliott LLP
The CNESST Requires That Medical Masks Be Worn Continuously Indoors In Workplaces
Stikeman Elliott LLP
Stikeman Elliott LLP
Popular Contributors
Goodwin Procter LLP
United States
Turnpenny Milne
Canada
Fasken (French)
Canada
Upcoming Events
MAY13
Conference Orlando United States
Mondaq Advice Centres
